FDA NDC Directory · JSON-LD · Markdown

Haloperidol

NDC 0615-8355 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerNCS HealthCare of KY, LLC dba Vangard Labs
Marketing categoryAbbreviated NDA (generic) · App ANDA211061
Dosage form / routeTABLET · ORAL
Active ingredientsHALOPERIDOL (5 mg/1)
Marketing started20200109
Marketing ended20260531
Package count1

External sources

Source: openFDA. Public-domain (CC0).